Left ventricular assist device (LVAD) implantation
LVAD implantation means placing a pump that helps the left ventricle, the main pumping chamber of the heart, to move blood. The US approval orders for one system, HeartMate 3, name people with advanced refractory left ventricular heart failure (heart failure that is advanced and does not respond to treatment) and describe short- and long-term support, including bridge to transplant, bridge to recovery and destination therapy (support as the long-term treatment). This page also records the registry entry of MOMENTUM 3, a study of HeartMate 3 against HeartMate II with 1028 people enrolled. No outcome is stated here.
Also called LVAD implantation
- Intervention
- In this atlas
Overview
Technical summary
MeSH descriptor D006353 (Heart-Assist Devices) is a broad match: its scope note describes small pumps, often implantable, for temporarily assisting the heart, usually the left ventricle, so it is wider than durable support and names the device, not the operation. Evidence in this atlas: openFDA premarket approval P160054 (HeartMate 3; the original order and supplement S008) and the ClinicalTrials.gov record NCT02224755 (MOMENTUM 3), read as a registry entry only. The registry holds posted results that were not read. The device itself has its own page.
About this intervention
- Type
- Procedure
- Mechanism
- A pump that helps the left ventricle move blood is placed in or beside the heart; MeSH describes such pumps as small, often implantable, with a pumping chamber and a power source that may be partly or fully outside the body.
Classification codes
-
D006353
Claims and evidence
Context Adults aged 18 to 100 in the MOMENTUM 3 registry record: advanced refractory left ventricular heart failure
- Recipient
- Adult
- Population
- People with advanced refractory left ventricular heart failure, as the registry condition describes them. The registry gives a minimum age of 18 years and a maximum of 100 years.
- Care setting
- Implanted left ventricular assist system (registry intervention type: device)
- Geography
- United States (registry country list)
- Life stage
- Adults, 18 to 100 years (registry eligibility ages)
- Follow-up
- Not recorded here: the registry fields read include no outcome measures
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Advanced refractory left ventricular heart failure (registry condition)
- Excluded
- None stated
ClinicalTrials.gov record NCT02224755 (MOMENTUM 3, record last updated 27 June 2022, copy retrieved on 26 October 2026) describes a study of two device interventions, the HeartMate 3 left ventricular assist system and the HeartMate II left ventricular assist system, in people with advanced refractory left ventricular heart failure aged 18 to 100. It lists 1028 participants enrolled (actual count) and the overall status completed.
Applies to Adult Adults aged 18 to 100 in the MOMENTUM 3 registry record: advanced refractory left ventricular heart failure
- Certainty method
- Not assessed
- Limitations
- This claim records a registry entry, not a trial result. The registry record holds posted results, which were not read or recorded here. The registry lists Abbott Medical Devices as lead sponsor and Thoratec Corporation as collaborator, both industry sponsors. No outcome, benefit or harm is recorded.
- Last checked
- 2026-11-08
- Next evidence check due
- Not scheduled
Sources and citations (9)
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.identificationModule.briefTitle
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.designModule.enrollmentInfo.count
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.designModule.enrollmentInfo.type
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.conditionsModule.conditions[0]
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.armsInterventionsModule.interventions[0].name
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.armsInterventionsModule.interventions[1].name
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.statusModule.overallStatus
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.eligibilityModule.minimumAge
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
-
Supports ClinicalTrials.gov record NCT02224755
- Locator
- protocolSection.eligibilityModule.maximumAge
- How it applies
- Quoted at this locator.
- Retrieved
- Source effective date
- 2022-06-27
- Source state
- Current
- Version fingerprint
7ed21bb15c957b7cf6e448d302d367a181e503efccd8554eebf7096baa1c771c- Reuse basis
- Registry record. The feed commits an extract of the fields it reads, and keeps the raw record in a private archive named by its sha256. The ClinicalTrials.gov terms page is rendered by JavaScript and its text was not read by a script, so the redistribution basis is unverified; any quotation stays short.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Registry entry for MOMENTUM 3: HeartMate 3 against HeartMate II in advanced refractory left ventricular heart failure (no result recorded): Heart failure
Applies to Adult Adults aged 18 to 100 in the MOMENTUM 3 registry record: advanced refractory left ventricular heart failure
ClinicalTrials.gov record NCT02224755 (MOMENTUM 3, record last updated 27 June 2022, copy retrieved on 26 October 2026) describes a study of two device interventions, the HeartMate 3 left ventricular assist system and the HeartMate II left ventricular assist system, in people with advanced refractory left ventricular heart failure aged 18 to 100. It lists 1028 participants enrolled (actual count) and the overall status completed.Limitations. This claim records a registry entry, not a trial result. The registry record holds posted results, which were not read or recorded here. The registry lists Abbott Medical Devices as lead sponsor and Thoratec Corporation as collaborator, both industry sponsors. No outcome, benefit or harm is recorded.
Record details
- Record id
cardio:left-ventricular-assist-device-lvad-implantation- Content hash
717844f0466d6559798563a3214ecb4633b1c2a912a5af36e9735ff603707b5e